ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,734,000 | -35.9% | 61,700 | -58.9% | 0.02% | -40.6% |
Q3 2021 | $8,939,000 | +443.7% | 150,100 | +522.8% | 0.03% | +433.3% |
Q2 2021 | $1,644,000 | -59.9% | 24,100 | -59.2% | 0.01% | -68.4% |
Q1 2021 | $4,098,000 | +79.6% | 59,062 | +98.9% | 0.02% | +90.0% |
Q4 2020 | $2,282,000 | +377.4% | 29,700 | +364.1% | 0.01% | +400.0% |
Q3 2020 | $478,000 | +124.4% | 6,400 | +36.2% | 0.00% | 0.0% |
Q4 2019 | $213,000 | -36.6% | 4,700 | -35.9% | 0.00% | -33.3% |
Q3 2019 | $336,000 | +52.7% | 7,333 | +96.1% | 0.00% | +50.0% |
Q2 2019 | $220,000 | -46.6% | 3,740 | -59.3% | 0.00% | -33.3% |
Q1 2019 | $412,000 | -20.8% | 9,200 | -31.0% | 0.00% | 0.0% |
Q4 2018 | $520,000 | – | 13,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |